Condition
Microbiome, Human
Total Trials
6
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Unknown2
Not Yet Recruiting2
Active Not Recruiting1
Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07316465Not ApplicableRecruiting
Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis
NCT06794723Phase 2Not Yet Recruiting
A Probiotic Based Intervention in Pregnancies Complicated by GDM
NCT06922773Not Yet Recruiting
Between the Belly and the Brain: Distorted Gut-brain Crosstalk in Early-life Adversity
NCT04758715Not ApplicableActive Not RecruitingPrimary
Diet and Microbiome Longitudinal Monitoring With Food Intervention
NCT05299970Not ApplicableUnknown
Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women
NCT05738473UnknownPrimary
Effects of IAP-EOGBSD on Maternal Vaginal Microbiome, Offspring's Gut Microbiome and Metabolites.
Showing all 6 trials